Inmaculada López-Flores , Beatriz González-Alzaga , Desirée Romero-Molina , Antonio F. Hernández , Octavio Pérez-Luzardo , Andrea Acosta-Dacal , Ana Macías-Montes , Luis A. Henríquez-Hernández , Luis D. Boada , Dolors Pelegrí , Juan R. González , Marina Lacasaña
{"title":"Gestational exposure to organophosphate pesticides and maternal urine metabolomic profile in the GENEIDA birth cohort","authors":"Inmaculada López-Flores , Beatriz González-Alzaga , Desirée Romero-Molina , Antonio F. Hernández , Octavio Pérez-Luzardo , Andrea Acosta-Dacal , Ana Macías-Montes , Luis A. Henríquez-Hernández , Luis D. Boada , Dolors Pelegrí , Juan R. González , Marina Lacasaña","doi":"10.1016/j.etap.2025.104793","DOIUrl":null,"url":null,"abstract":"<div><div>Early developmental exposure to organophosphate (OP) pesticides has been linked to adverse health effects, though the underlying molecular pathways remain unclear. This study examined urinary metabolomic profiles of 387 pregnant women in their first and third trimesters using UPLC-MS/MS to identify metabolic disruptions associated with OPs exposure measured via dialkyl phosphate (DAPs) metabolites, including total, methyl and ethyl forms. Multiple linear regression models, adjusted for covariates and corrected for multiple comparisons revealed that first trimester OP exposure was significantly associated with 4-pyridoxic acid, a vitamin B6 metabolite. In the third trimester, OP exposure was linked to metabolites related to amino acid metabolism, synaptic function, cytochrome P450-mediated detoxification, cancer and immune pathways. These findings suggest that OP exposure may disrupt maternal metabolic processes during pregnancy, potentially affecting foetal development. This study highlights potential targets for future hypothesis-driven studies and potential interventions to mitigate OP pesticide exposure during pregnancy.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"118 ","pages":"Article 104793"},"PeriodicalIF":4.2000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668925001681","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Early developmental exposure to organophosphate (OP) pesticides has been linked to adverse health effects, though the underlying molecular pathways remain unclear. This study examined urinary metabolomic profiles of 387 pregnant women in their first and third trimesters using UPLC-MS/MS to identify metabolic disruptions associated with OPs exposure measured via dialkyl phosphate (DAPs) metabolites, including total, methyl and ethyl forms. Multiple linear regression models, adjusted for covariates and corrected for multiple comparisons revealed that first trimester OP exposure was significantly associated with 4-pyridoxic acid, a vitamin B6 metabolite. In the third trimester, OP exposure was linked to metabolites related to amino acid metabolism, synaptic function, cytochrome P450-mediated detoxification, cancer and immune pathways. These findings suggest that OP exposure may disrupt maternal metabolic processes during pregnancy, potentially affecting foetal development. This study highlights potential targets for future hypothesis-driven studies and potential interventions to mitigate OP pesticide exposure during pregnancy.
期刊介绍:
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.